SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated (SBC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · SBC · as of Mar 31, 2025
Ownership Breakdown
1
Institutional Holders
▲ 1 vs Q4
$3
Total Inst. Value
▲ $3 vs Q4
102.85M
Shares Outstanding
freeFloat 2.40%
1
13F Shares Held
▲ 1 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
SBC largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
HUNTINGTON NATIONAL BANK services-offices & clinics of doctors of medicine | 1 | 0.00% | 0.00% | $24,000 | May 14, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
SBC insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
2
Sell transactions
0.00
Buy/Sell ratio
$4M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Aikawa Yoshiyuki Chairman and CEO | Apr 28, 2026 | Sale | 465,000 | $3.02 | $1.41M | 78.84M | Form 4 ↗ |
Aikawa Yoshiyuki Chairman and CEO | Apr 21, 2026 | Sale | 3,100,000 | $3.02 | $9.37M | 79.30M | Form 4 ↗ |
Aikawa Yoshiyuki Chairman and CEO | Mar 6, 2026 | Sale | 4,422,900 | $2.12 | $9.38M | 861.6K | Form 4 ↗ |
Aikawa Yoshiyuki Chairman and CEO | Mar 6, 2026 | J-Other | 44,229 | $2.12 | $93.8K | 44.2K | Form 4 ↗ |
Aikawa Yoshiyuki Chairman and CEO | Mar 6, 2026 | J-Other | 44,229 | $2.12 | $93.8K | 44.2K | Form 4 ↗ |
SAYAMA MIKE K director | Sep 30, 2024 | J-Other | 15,000 | — | — | 15.0K | Form 4 ↗ |
ZUU Co. Ltd. 10 percent owner | Sep 17, 2024 | J-Other | 1,503,473 | — | — | 2.93M | Form 4 ↗ |
ZUU Co. Ltd. 10 percent owner | Sep 19, 2024 | Sale | 6,196 | $7.34 | $45.5K | 2.92M | Form 4 ↗ |
ZUU Co. Ltd. 10 percent owner | Sep 17, 2024 | J-Other | 1 | $0.01 | $0.01 | 2.33M | Form 4 ↗ |
Aikawa Yoshiyuki Director, Chairman and CEO | Sep 17, 2024 | J-Other | 1,503,473 | — | — | 92.96M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
SBC Medical Group Holdings Incorporated (SBC) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 97.60%, while retail and public investors account for the remaining 2.40%.
The largest institutional shareholder of SBC Medical Group Holdings Incorporated is HUNTINGTON NATIONAL BANK, holding approximately 1 shares — equal to — of outstanding shares — as of March 31, 2025.
A total of 1 institutional investors currently hold SBC stock, with a combined institutional value of approximately $3 as of the most recent 13F filing period.
Frequently asked questions
SBC ownershipSBC Medical Group Holdings Incorporated (SBC) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is HUNTINGTON NATIONAL BANK with a — stake. Company insiders hold 97.60%. Data sourced from SEC Form 13F as of March 31, 2025.